New Key Statistics Module, Z-Score and F-Score
NAS:ABCL Key Ratios
| Market Cap $ M | 1,064.48 |
| Enterprise Value $ M | 440.06 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.94 |
| Price/Sales | 29.19 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 35.00 |
| EPS (TTM) $ | -0.52 |
| Beneish M-Score | -2.04 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.06 |
| EV-to-EBITDA | -2.41 |
| PEG | -- |
| Shares Outstanding M | 294.05 |
| Net Margin (%) | -410.47 |
| Operating Margin % | -595.65 |
| Pre-tax Margin (%) | -471.19 |
| Quick Ratio | 7.75 |
| Current Ratio | 7.76 |
| ROA % (ttm) | -9.80 |
| ROE % (ttm) | -12.52 |
| ROIC % (ttm) | -28.50 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.37 |
ABCL Number of Guru Trades
ABCL Volume of Guru Trades
Gurus Latest Trades with NAS:ABCL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ABCL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AbCellera Biologics Inc Insider Transactions
No Available Data
News about NAS:ABCL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers